Search by Drug Name or NDC

    NDC 53451-0101-01 Horizant 600 mg/1 Details

    Horizant 600 mg/1

    Horizant is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals). The primary component is GABAPENTIN ENACARBIL.

    Product Information

    NDC 53451-0101
    Product ID 53451-0101_5b1d346e-2db1-4c2a-baf5-a4598642a4e7
    Associated GPIs 62560030200430
    GCN Sequence Number 067351
    GCN Sequence Number Description gabapentin enacarbil TABLET ER 600 MG ORAL
    HIC3 H6L
    HIC3 Description DRUGS TO TREAT MOVEMENT DISORDERS
    GCN 29888
    HICL Sequence Number 037574
    HICL Sequence Number Description GABAPENTIN ENACARBIL
    Brand/Generic Brand
    Proprietary Name Horizant
    Proprietary Name Suffix n/a
    Non-Proprietary Name gabapentin enacarbil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600
    Active Ingredient Units mg/1
    Substance Name GABAPENTIN ENACARBIL
    Labeler Name Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)
    Pharmaceutical Class Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA022399
    Listing Certified Through 2024-12-31

    Package

    NDC 53451-0101-01 (53451010101)

    NDC Package Code 53451-0101-1
    Billing NDC 53451010101
    Package 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (53451-0101-1)
    Marketing Start Date 2013-05-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 16.5286
    Pricing Unit EA
    Effective Date 2024-01-01
    NDC Description HORIZANT ER 600 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis